Apalutamide – November 2021

• Brand names:
  • Erlyand®
• Pharmaceutical Company:
  • Janssen-Cilag Pty Ltd
• Condition/Indication: Prostate cancer
• Meeting Date: November 2021
• Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1342KB)
• Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 282KB)

Related Public Summary Documents

• Apalutamide – July 2019
• Apalutamide ˜ November 2020